My Legacy Advisors LLC Cuts Position in HCA Healthcare, Inc. (NYSE:HCA)

My Legacy Advisors LLC trimmed its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 5.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,642 shares of the company’s stock after selling 192 shares during the period. My Legacy Advisors LLC’s holdings in HCA Healthcare were worth $1,115,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Benjamin F. Edwards & Company Inc. acquired a new stake in HCA Healthcare in the 2nd quarter valued at $33,000. Legacy Investment Solutions LLC purchased a new stake in shares of HCA Healthcare during the 3rd quarter valued at about $39,000. Canoe Financial LP acquired a new stake in HCA Healthcare in the third quarter valued at approximately $41,000. Capital Performance Advisors LLP purchased a new position in shares of HCA Healthcare in the third quarter valued at $41,000. Finally, Northwest Investment Counselors LLC acquired a new position in HCA Healthcare in the 3rd quarter worth $44,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insiders Place Their Bets

In other news, insider Erol R. Akdamar sold 2,900 shares of the business’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the sale, the insider now directly owns 6,843 shares of the company’s stock, valued at $2,415,579. The trade was a 29.76 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the transaction, the senior vice president now directly owns 52,702 shares in the company, valued at $18,445,700. This represents a 6.89 % decrease in their position. The disclosure for this sale can be found here. 1.70% of the stock is owned by insiders.

HCA Healthcare Stock Performance

Shares of NYSE HCA opened at $310.60 on Friday. The stock has a 50 day simple moving average of $316.69 and a 200-day simple moving average of $352.78. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. The company has a market cap of $78.68 billion, a PE ratio of 13.95, a P/E/G ratio of 1.03 and a beta of 1.64. HCA Healthcare, Inc. has a 12-month low of $278.50 and a 12-month high of $417.14.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, December 27th. Investors of record on Friday, December 13th were given a $0.66 dividend. The ex-dividend date was Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a yield of 0.85%. HCA Healthcare’s dividend payout ratio is presently 11.85%.

Wall Street Analyst Weigh In

HCA has been the topic of several recent analyst reports. Truist Financial cut their price target on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Cantor Fitzgerald reissued an “overweight” rating and set a $392.00 price target on shares of HCA Healthcare in a research report on Tuesday, October 1st. KeyCorp decreased their price objective on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a report on Tuesday, January 7th. Wells Fargo & Company downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and decreased their price target for the stock from $400.00 to $320.00 in a research note on Monday, November 25th. Finally, Morgan Stanley decreased their target price on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research report on Tuesday, December 17th. One analyst has rated the stock with a sell rating, three have given a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus target price of $385.27.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.